Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of Pseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance

Clare C. Walsh, Cornelia B. Landersdorfer, Michelle P. McIntosh, Anton Y. Peleg, Elizabeth B. Hirsch, Carl M. Kirkpatrick, Phillip J. Bergen

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of Pseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance'. Together they form a unique fingerprint.

Medicine & Life Sciences